In terms of revenue, the Global Disposable Ureteroscope Market is expected to reach USD 4,098.1 Million by 2028, and the market is expected to grow at a Compound Annual Growth Rate (CAGR) of 15.5% from 2022 to 2028.
The increasing prevalence of Urolithiasis and adopting disposable products are anticipated to augment the market's growth during the forecast period.
Key Highlights from Report:
- The Flexible Ureteroscope sub-segment held a significant share in 2021. The percentage is attributable to the rising number of procedures using fiber optics and flexible digital ureteroscopy. The Urolithiasis sub-segment is projected to grow at a considerable Compound Annual Growth Rate (CAGR) during the forecast period. This growth is attributable to the growing occurrence of global urological cancer.
- The hospital's segment held a significant share in 2021. The percentage is attributable to the number of patient admissions in hospitals. Further, the growing number of chronic kidney disorders results in a high rate of hospitalization that contributes to the rising demand for disposable ureteroscopy in this segment, which is expected to strengthen the growth in the future.
- Asia Pacific is expected to grow at the fastest Compound Annual Growth Rate (CAGR) during the forecast period. China held the largest share in APAC in 2021. This growth is due to the government's increased investment in healthcare infrastructure in the region's economies, such as China and India. Furthermore, the growing elderly population and an increase in medical tourism are expected to drive regional market growth in the years to come.
The increasing prevalence of Urolithiasis across developing and developed economies is anticipated to augment the future growth of the Disposable Ureteroscope market. Urinary stones are becoming more common due to metabolic disorders, hereditary factors, urinary tract anomalies, changing lifestyles, and environmental issues such as global warming. Furthermore, the growing senior population, which is more sensitive to kidney problems, is expected to accelerate the rate of occurrence.
Stone formation is linked to type-2 diabetes and coronary artery disease. According to an article published by the National Center for Biotechnology Information (NCBI), kidney stones afflict about 9% of persons in the United States, with 600 thousand Americans suffering from urinary stones each year. As a result, the demand for ureteroscopy is predicted to increase as the number of urinary stone cases is forecast to rise during the projection period.
North America held the most significant shares in 2021. The U.S. had the largest share in the region for the Global Disposable Ureteroscope market. This share is attributable to the developed healthcare infrastructure in the area. Furthermore, the increase in cases of Urolithiasis and the high demand for minimally invasive procedures are also likely to fuel the regional growth of the market. Additionally, the affordability and availability of advanced ureteroscopy are expected to support the market's growth in the region.